The Global Health program at the Council on Foreign Relations (CFR) provides independent, evidence-based analysis and recommendations to help policymakers, practitioners, business leaders, journalists, and the public meet the health challenges of a globalized world. These challenges include infectious diseases such as COVID-19 and monkeypox that cross borders with easier trade and travel, the rapid increase in cancers, diabetes, and other noncommunicable diseases in working-age people in developing countries, and the emerging perils of antibiotic resistance and climate change. These changing health needs place new demands on international institutions and initiatives at a time when their long-term financing is in doubt. Through rigorous research, articles, and online-interactives, CFR's experts work to advance evidence-based analysis and informed decision-making in global health.
Yanzhong Huang, a senior fellow for global health at the Council and professor and director of global health studies at Seton Hall University's School of Diplomacy and International Relations, and Zongyuan Zoe Liu, a fellow for international political economy at the Council, sit down with James M. Lindsay to discuss the consequences of China’s decision to end its zero-COVID policy.
This interactive examines how nationwide bans on menthol cigarettes and flavored cigars, as proposed by the Biden administration on April 28, 2022, could help shrink the racial gap on U.S. lung cancer death rates.
China's ambitions for global health leadership are faltering as the COVID-19 pandemic persists. The country's mixed record of addressing the virus offers opportunities for U.S. global health leadership, writes Yanzhong Huang.